Stelexis Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
January 8, 2019
Vertical
Cancer Therapeutics
Funding Amount
$43,000,000
Company Info
Market
Cancer Treatment
Location
New York, NY, USA
Coinvestors
Deerfield Partners
Company Description

Stelexis Therapeutics is a company utilizes pre-cancerous stem cells to discover and develop transformative therapies.